ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Hepatic impacts of gold nanoparticles with different surface coatings as revealed by assessing the hepatic drug-metabolizing enzyme and lipid homeostasis in mice

Zhou, Shuang; Li, Xue; Zhu, Meilin; Yu, Hongyang; Chu, Runxuan; Chen, Wei; Wang, Bing; Wang, Meng; Zheng, Lingna; Chai, Zhifang; Chen, Hanqing*; Feng, Weiyue*苏州大学; 烟台大学; 中国科学院研究生院; 中国科学院; 1
NanoImpact2020-10DOI: 10.1016/j.impact.2020.100259
13被引5阅读
引用收藏
分享

摘要

Liver is the major organ in the metabolization of drugs, and detoxification of exogenous substances, including nanoparticles. In clinical medical practice, drug-induced liver injury (DILI) is the major cause of acute liver failure (ALF). In this study, we explore the possible impact of intravenously injected citrate acid (CA), chitosan (CS) and polyethyleneglycol (PEG) functionalized gold nanoparticles (GNPs) on the liver of mice at the doses (60 and 120 mu g/mouse) relevant to their biomedical applications. Overall, the results provide the evidence that all the GNPs did not induce obvious liver injury and hepatic steatosis in mice. However, the study highlights that alteration in the function of drug-metabolizing enzymes in the HepaRG cells was associated with the increase cytotoxicity of GNP treatments. Moreover, the deposited GNPs in the liver disturb the expression of drug -metabolizing enzymes, including drug uptake and efflux transporters, and cytochrome P450 (CYP450) isoforms and phase II metabolized enzymes. The mechanism of GNP-induced hepatotoxicity in mice is associated with hyperactivation of mTOR signalling and SREBP-1c-mediated de novo lipogenesis with hepatic inflammation. This also suggests that when using GNPs for biomedical applications, it is necessary to consider the influence of nanomaterial-liver interaction and nanomaterial-induced hepatotoxicity on drug-metabolizing enzymes and lipid homeostasis.

学科与关键词

关键词
Gold nanoparticlesNanomaterial-liver interactionDrug-metabolizing enzymeCytochrome P450Lipid metabolismMechanistic target of rapamycin
相关
加载中…
  • Gold Nanoparticles Modified With Polyethyleneimine Disturbed the Activity of Drug-Metabolic Enzymes and Induced Inflammation-Mediated Liver Injury in Mice
    Chen, Hanqing*; Zhou, Shuang; Zhu, Meilin; Wang, Bing; Chen, Wei; Zheng, Lingna; Wang, Meng; Feng, Weiyue*Frontiers in Pharmacology, 2021, 12: 706791.被引 7
  • AgNPs Aggravated Hepatic Steatosis, Inflammation, Oxidative Stress, and Epigenetic Changes in Mice With NAFLD Induced by HFD
    Wen, Ling; Li, Minyan; Lin, Xiaojun; Li, Yan; Song, Huidong*; Chen, Hanqing*Frontiers in Bioengineering and Biotechnology, 2022, 10: 912178.被引 11
  • Nanomaterials and hepatic disease: toxicokinetics, disease types, intrinsic mechanisms, liver susceptibility, and influencing factors
    Sun, Ting*; Kang, Yiyuan; Liu, Jia; Zhang, Yanli; Ou, Lingling; Liu, Xiangning; Lai, Renfa; Shao, Longquan*JOURNAL OF NANOBIOTECHNOLOGY, 2021, 19(1): 108.被引 22
查看全部 →

发表信息

论文状态
公开发表
期刊
NanoImpact
发表日期
2020-10
卷期
第 20 卷
页码
100259
DOI
10.1016/j.impact.2020.100259
期刊收录
NSL.SCIE
期刊等级
3区
成果收录
SCIE
资助标注
National Key Research and Development Project [2016YFA0201603]; National Natural Science Foundation of China [11775234, 11975251, 11875268]

作者

  • Z

    Zhou, Shuang (第一作者)

    cas · chinese acad sci · univ chinese acad sci

  • L

    Li, Xue

    cas · chinese acad sci · univ chinese acad sci

查看全部 12 位作者收起作者
  • Z

    Zhu, Meilin

    cas · chinese acad sci · anhui univ

  • Y

    Yu, Hongyang

    cas · chinese acad sci · yantai univ

  • C

    Chu, Runxuan

    anhui univ

  • C

    Chen, Wei

    cas · chinese acad sci · univ chinese acad sci

  • W

    Wang, Bing

    cas · chinese acad sci

  • W

    Wang, Meng

    cas · chinese acad sci

  • Z

    Zheng, Lingna

    cas · chinese acad sci

  • C

    Chai, Zhifang

    cas · chinese acad sci · soochow univ · x

  • C

    Chen, Hanqing (通讯)

    cas · chinese acad sci · 1

  • F

    Feng, Weiyue (通讯)

    cas · chinese acad sci

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417